2121 - 2130 of 6560 Results
Title
Year
- Early-Onset Parkinsonism and Early-Onset Parkinson’s Disease: A Population-Based Study (2010-2015)2021OPENTitle: Early-Onset Parkinsonism and Early-Onset Parkinson’s Disease: A Population-Based Study (2010-2015)Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1197End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202464Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8355040Citation Count: 49
-
OPENTitle: Choroidal Thickness Correlates with Clinical and Imaging Metrics of Parkinson’s Disease: A Pilot StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1857End Page: 1868Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212676Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530855Citation Count: 13
-
OPENTitle: Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer’s diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 95Issue #:Start Page: 56End Page: 68Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.06.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7609500Citation Count: 25
-
OPENTitle: Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 134Issue #:Start Page: 104623End Page: 104623Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104623Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996119302980?via%3DihubCitation Count: 107
-
OPENTitle: Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entryJournal Name: Drug and Alcohol DependencePublisher: Elsevier BVVol: 206Issue #:Start Page: 107728End Page: 107728Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.drugalcdep.2019.107728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6980652Citation Count: 3
-
OPENTitle: Personalized care management for persons with Parkinson's disease: A telenursing solutionJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 3Issue #:Start Page: 100070End Page: 100070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100070Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100070Citation Count: 11
-
OPENTitle: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's DiseaseJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 40Issue #: 35Start Page: 6812End Page: 6819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1523/jneurosci.0610-20.2020Best OA location URL: https://www.jneurosci.org/content/jneuro/40/35/6812.full.pdfCitation Count: 29
-
OPENTitle: Questioning the Meaning of a Change on the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over TimeJournal Name: AssessmentPublisher: SAGE PublicationsVol: 28Issue #: 6Start Page: 1708End Page: 1722Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1073191120915273Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1073191120915273Citation Count: 10
-
OPENTitle: Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNAJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 117Issue #: 3Start Page: 1457End Page: 1467Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1905057117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1457.full.pdfCitation Count: 121
-
OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 25